Ariel Berlinski Institution-verified
Sourced from institutional research profiles (UAMS TRI or ARA).
Professor
faculty
Research Areas
Biography and Research Information
OverviewAI-generated summary
Ariel Berlinski's research centers on respiratory therapies, particularly in the context of cystic fibrosis and critical care. Berlinski has investigated aerosol delivery systems and strategies, including the use of nebulizers and vaporizers for drug administration through various respiratory support modes. This work has involved evaluating the efficacy and safety of different therapeutic agents and delivery methods in both adult and pediatric populations.
Berlinski's publications include studies on the long-term outcomes of treatments for cystic fibrosis, such as the efficacy of modulator therapies and the management of hypertonic saline and dornase alfa. Additionally, Berlinski has contributed to guidelines for pediatric oxygen therapy and explored the implementation of protocols for spirometry and asthma education in primary care settings. Research has also examined the relationship between nutritional status and the development of cystic fibrosis-related diabetes in adolescents.
With a h-index of 25 and over 1,900 citations across 154 publications, Berlinski is recognized as a highly cited researcher. Key collaborators at the University of Arkansas for Medical Sciences include K. Agoramurthi, Zena Ghazala, L. Denise Willis, and M. Pertzborn, with whom Berlinski has co-authored multiple publications. Berlinski also leads a research group focused on these areas.
Metrics
- h-index: 25
- Publications: 170
- Citations: 1,865
Selected Publications
-
Understanding Nebulizer Utilization by Patients and Healthcare Providers: A COPD Foundation Nebulizer Consortium Survey Study (2026)
-
Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease (2025)
-
Mobile Health App for Adolescent Asthma Self-Management: Development and Usability Study of the Pulmonary Education and Knowledge Mobile Asthma Action Plan (2025)
-
Use of Digital Health in Pediatric Asthma (2025)
-
Aerosol Delivery Challenges and Strategies for Pediatric Asthma (2025)
-
Drug Delivery via Intrapulmonary Percussion Ventilator: Time to Follow Queen Elsa’s Advice (2024)
-
Incorporating the perspectives of participants and research coordinators on home spirometry into clinical trial design: The example of the OUTREACH study (2024)
-
Impact of Using New Formula for Calculation of Bronchodilator Response and Race-neutral Predictive Equations on Spirometry Results of Children With Sickle Cell Disease (2024)
-
An Unusual Case of Chronic Cough (2024)
-
Necrotizing Pneumonia in a Young Adult With Cystic Fibrosis (2024)
-
Effects of Adoption of Race Neutral Predictive Equations on Spirometry Results in Pediatric Sickle Cell Patients (2024)
-
Effect of Disinfection Method and Testing Methodology on the Performance of a Breath-Enhanced Jet Nebulizer (2023)
-
455 Performance of a breath-enhanced nebulizer after repeated cycles of thermal or chemical disinfection (2023)
-
Albuterol Delivery During Invasive Mechanical Ventilation via In-Line Intrapulmonary Percussive Ventilation in a Pediatric Lung Model (2023)
-
Innovation in Drug Delivery Through High-Flow Nasal Cannula Systems and Its Evaluation (2023)
Grants & Funding
Collaboration Network
Top Collaborators
- Necrotizing Pneumonia in a Young Adult With Cystic Fibrosis
- Effect of Disinfection With Baby-bottle Sterilizer of Reusable Breath-enhanced Nebulizers on Aerosolized Albuterol Output and Characteristics
- 455 Performance of a breath-enhanced nebulizer after repeated cycles of thermal or chemical disinfection
- Effect of Disinfection Method and Testing Methodology on the Performance of a Breath-Enhanced Jet Nebulizer
- Albuterol Delivery Through Laryngeal Mask Airways
- Effect of In-Line Intrapulmonary Percussive Ventilation on Respiratory Pressures During Simulated Pediatric Invasive Ventilation
- Curriculum and Competency Evaluation in Respiratory Entry to Practice Programs
- Use of Continuous Albuterol in a Pathway for Treatment of Pediatric Acute Asthma
- Practices for High Frequency Chest Compression in Children
- Implementation of a Respiratory Therapist–Driven Protocol for Spirometry and Asthma Education in a Pediatric Out-Patient Primary Care Setting
- Safe and Effective Use of Score-Based Continuous Albuterol Therapy in a Pathway for Treatment of Pediatric Asthma Exacerbation
- Albuterol Delivery During Invasive Mechanical Ventilation via In-Line Intrapulmonary Percussive Ventilation in a Pediatric Lung Model
- Curriculum and Competency Evaluation in Respiratory Therapy Entry-to-Practice Programs
- Mobile Health App for Adolescent Asthma Self-Management: Development and Usability Study of the Pulmonary Education and Knowledge Mobile Asthma Action Plan
- Implications of removing race from spirometry reference equations in children with asthma
- Implications of Removing Race from Spirometry Reference Equations in Children with Asthma
- Access to Digital Technology among Teens with Asthma: A Barrier or Facilitator of Mobile Health Interventions?
- Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease
- Necrotizing Pneumonia in a Young Adult With Cystic Fibrosis
- Effects of Adoption of Race Neutral Predictive Equations on Spirometry Results in Pediatric Sickle Cell Patients
- Impact of Using New Formula for Calculation of Bronchodilator Response and Race-neutral Predictive Equations on Spirometry Results of Children With Sickle Cell Disease
- Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials
- Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study
- Incorporating the perspectives of participants and research coordinators on home spirometry into clinical trial design: The example of the OUTREACH study
- Home Spirometry in Children with Cystic Fibrosis
- 714 Impact of the triple modulator therapy (elexacaftor-tezacaftorivacaftor) on children with cystic fibrosis: single-center report
- Diagnosis Accuracy and Crosschecking Data Entries in Medical Records and Cystic Fibrosis Foundation Patient Registry: A Quality Improvement Project
- Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease
- Effects of Adoption of Race Neutral Predictive Equations on Spirometry Results in Pediatric Sickle Cell Patients
- Impact of Using New Formula for Calculation of Bronchodilator Response and Race-neutral Predictive Equations on Spirometry Results of Children With Sickle Cell Disease
- Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease
- Effects of Adoption of Race Neutral Predictive Equations on Spirometry Results in Pediatric Sickle Cell Patients
- Impact of Using New Formula for Calculation of Bronchodilator Response and Race-neutral Predictive Equations on Spirometry Results of Children With Sickle Cell Disease
- Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease
- Effects of Adoption of Race Neutral Predictive Equations on Spirometry Results in Pediatric Sickle Cell Patients
- Impact of Using New Formula for Calculation of Bronchodilator Response and Race-neutral Predictive Equations on Spirometry Results of Children With Sickle Cell Disease
- Effects of Shake-Actuation Delay on Delivered Dose and Aerosol Characteristics of an Albuterol Suspension From a Pressurized Metered-Dose Inhaler
- A Case of Eikenella Corrodens Causing Cystic Fibrosis Exacerbation
- Nutritional status between 5‐10 years is associated with cystic fibrosis‐related diabetes in adolescence
- Diagnosis Accuracy and Crosschecking Data Entries in Medical Records and Cystic Fibrosis Foundation Patient Registry: A Quality Improvement Project
- Curriculum and Competency Evaluation in Respiratory Therapy Entry-to-Practice Programs
- Curriculum and Competency Evaluation in Respiratory Entry to Practice Programs
- Curriculum and Competency Evaluation in Respiratory Therapy Entry-to-Practice Programs
- Curriculum and Competency Evaluation in Respiratory Entry to Practice Programs
- Home Spirometry in Children with Cystic Fibrosis
- 163: Implementation of a pediatric home spirometry program for patients with cystic fibrosis
Similar Researchers
Based on overlapping research topics